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Hyperlipemia often occurs in the patients with obesity and type 2 diabetes, and is also primary trigger for cardiac remodeling and dysfunction. 
Stromal cell-derived factor-1beta (SDF-1β) was cardiac protective, but whether it also protects the cardiac cells from high fat-induced remodeling 
remains unknown. By using H9c2 cardiac cell line, we observed the effect of SDF-1β on saturated free fatty acid-induced fibrotic response. Exposure 
of H9c2 cells to palmitate at 62.5 µM for 15 h caused a significant fibrotic effect, shown by up-regulation of CTGF, TGF-β and KLF4, which is by 
activating NADPH oxidase-associated nitrosative damage and endoplasmic reticulum stress. Pretreatment with SDF-1β significantly prevented 
palmitate-induced fibrosis along with significant increases in AMPK-mediated p38 MAPK activation and IL-6 generation. AMPK activator significantly 
prevents palmitate-induced cardiac fibrosis while AMPK inhibitor prohibited SDF-1β’s protective effect. P38β MAPK siRNA significantly prevents 
SDF-1β’s anti-fibrotic effect. Direct addition of recombinant human IL-6 to cell cultures prevented palmitate-induced fibrosis whereas IL-6 siRNA 
abolished the protective effect of SDF-1β. CXCR7 siRNA, but not CXCR4 siRNA, abolished SDF-1β’s protective effect and above related signaling 
pathways. The anti-fibrotic effect of SDF-1β observed in H9c2 cells was also confirmed in the primary cultures of neonatal cardiomyocytes. These 
in vitro results suggest that SDF-1β prevents palmitate-induced cardiac fibrosis via its receptor CXCR7 and further activating AMPK/p38 MAPK-
mediated IL-6 excretion. In vivo studies, by using type 2 diabetes models, we confirmed that high-fat diet induced cardiac fibrosis, and that SDF-1β 
prevented high fat diet-induced cardiac fibrosis along with its activation of AMPK. This important finding opens a new road for the research of SDF-
1β’s cardiac protection that is irrelevant with its well-known function of stem cell mobilization.
